Ex-Vivo Preservation with the Organ Care System in High Risk Heart Transplantation.
OCS heart
cardiac transplantation
ex vivo organ perfusion
heart transplantation
organ care system
Journal
Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444
Informations de publication
Date de publication:
07 Feb 2022
07 Feb 2022
Historique:
received:
05
01
2022
revised:
25
01
2022
accepted:
25
01
2022
entrez:
25
2
2022
pubmed:
26
2
2022
medline:
26
2
2022
Statut:
epublish
Résumé
Ex vivo organ perfusion is an advanced preservation technique that allows graft assessment and extended ex situ intervals. We hypothesized that its properties might be especially beneficial for high-risk recipients and/or donors with extended criteria. We reviewed the outcomes of 119 consecutive heart transplant patients, which were divided into two groups: A (OCS) vs. B (conventional). Ex vivo organ perfusion was performed using the Organ Care System (OCS). Indications for OCS-usage were expected ischemic time of >4 h or >2 h plus given extended donor criteria. Both groups included mostly redo cases (A: 89.7% vs. B: 78.4%; OCS heart allowed safe transplantation of surgically complex recipients with excellent one-year outcomes, despite long preservation times and unfavourable donor characteristics. Furthermore, we observed trends towards decreased ventilation times and fewer ECLS treatments. In times of reduced organ availability and increasing recipient complexity, OCS heart is a valuable instrument that enables otherwise infeasible allocations and contributes to increase surgical safety.
Identifiants
pubmed: 35207534
pii: life12020247
doi: 10.3390/life12020247
pmc: PMC8877453
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Transplant Proc. 2020 Apr;52(3):949-953
pubmed: 32143873
Can J Surg. 2017 Sep;60(5):305-310
pubmed: 28805187
J Thorac Cardiovasc Surg. 2020 Mar;159(3):865-896
pubmed: 31983522
Ann Cardiothorac Surg. 2018 Jan;7(1):67-74
pubmed: 29492384
Int J Artif Organs. 2020 Apr 23;:391398820915476
pubmed: 32323596
Ann Cardiothorac Surg. 2020 Mar;9(2):98-103
pubmed: 32309157
J Heart Lung Transplant. 2017 Mar;36(3):258-263
pubmed: 27646064
Qual Life Res. 2020 Jun;29(6):1631-1639
pubmed: 32016682
J Thorac Cardiovasc Surg. 2020 May;159(5):e307-e309
pubmed: 31672395
J Heart Lung Transplant. 2016 Dec;35(12):1443-1452
pubmed: 27916176
Ann Thorac Surg. 2014 Dec;98(6):2099-105; discussion 2105-6
pubmed: 25443013
J Heart Lung Transplant. 2020 Oct;39(10):997-1002
pubmed: 32896477
Eur J Cardiothorac Surg. 2019 Jun 1;55(Suppl 1):i38-i48
pubmed: 31106338
J Heart Lung Transplant. 2020 Oct;39(10):1003-1015
pubmed: 32811772
J Heart Lung Transplant. 2019 Aug;38(8):858-869
pubmed: 31072751
Eur J Cardiothorac Surg. 2021 Jul 14;60(1):177-185
pubmed: 33783490
Lancet Respir Med. 2018 May;6(5):357-367
pubmed: 29650408
Lancet Respir Med. 2019 Nov;7(11):975-984
pubmed: 31378427
Eur J Cardiothorac Surg. 2019 Jun 1;55(6):1136-1143
pubmed: 30649307
Interact Cardiovasc Thorac Surg. 2019 Sep 1;29(3):422-429
pubmed: 31098641
Chirurg. 2019 Feb;90(2):110-116
pubmed: 30607463
J Thorac Dis. 2018 Apr;10(Suppl 8):S910-S923
pubmed: 29744218
Lancet. 2015 Jun 27;385(9987):2577-84
pubmed: 25888086
Lancet. 2012 Nov 24;380(9856):1851-8
pubmed: 23063317
J Am Coll Cardiol. 2019 Apr 2;73(12):1447-1459
pubmed: 30922476
J Thorac Cardiovasc Surg. 2019 Feb;157(2):603-610
pubmed: 30669225
J Heart Lung Transplant. 2017 Dec;36(12):1319-1321
pubmed: 29173395
Lancet. 2015 Jun 27;385(9987):2585-91
pubmed: 25888085
Eur J Cardiothorac Surg. 2019 Aug 1;56(2):230-270
pubmed: 31100109
ASAIO J. 2021 Aug 1;67(8):862-868
pubmed: 34039886